Evidence map›Paper›PMID 19752220›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2009

Efficient cross-priming of antiviral CD8+ T cells by antigen donor cells is GRP94 independent.

Avital Lev, Peniel Dimberu, Suman R Das, Jason C Maynard, Christopher V Nicchitta, Jack R Bennink, Jonathan W Yewdell

Erratum issuedOpen access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. MHC class I antigen processing distinguishes endogenous antigens based on their translation from cellular vs. viral mRNA.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. GRP94 in ER quality control and stress responses.Seminars in cell & developmental biology · 2010
    Review
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Avital LevLaboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA.
Peniel Dimberu
Suman R Das
Jason C Maynard
Christopher V Nicchitta
Jack R Bennink
Jonathan W Yewdell
National Institute of Allergy and Infectious Diseases · USDuke University · US

Funding

Delivery Of Antigens To The MHC Class I Processing PathwayZIAAI000653 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI YEWDELL, JONATHAN W · 2009 to 2015
$2.8M
DELIVERY OF ANTIGENS TO THE MHC CLASS PROCESSING PATHWAYZ01AI000653 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI YEWDELL, JONATHAN W · 1992 to 2008
$1.6M
Mechanism of Chaperone-Mediated Tumor RejectionR01CA104392 · NCI · DUKE UNIVERSITY · PI NICCHITTA, CHRISTOPHER V. · 2004 to 2008
$1.2M
Intramural NIH HHS Z01 AI000653NCI NIH HHS CA104392NCI NIH HHS R01 CA104392
6 · The paper itself

Abstract

Cross-priming, the activation of naive CD8+ T cells by dendritic cells presenting Ags synthesized by other cells, is believed to play an important role in the generation of antiviral and antitumor responses. The molecular mechanism(s) underlying cross-priming remain poorly defined and highly controversial. GRP94 (gp96), an abundant endoplasmic reticulum chaperone with innate immune-activating capacity, has been widely reported to play a major role in cross-priming. In this study, we show that cells whose expression of GRP94 is silenced via transient or stable transfection with GRP94-directed small interfering RNAs demonstrate no reduction in their abilities to generate class I peptide complexes in cultured cells or to prime antiviral CD8+ T cell responses in vivo. In demonstrating the dispensability of GRP94, our finding points to the importance of alternative mechanisms for generation of class I peptide complexes from endogenous and exogenous Ags and immunogens.

Indexed as

AnimalsAntigens, ViralAntiviral AgentsCD8-Positive T-LymphocytesCell LineCross-PrimingFemaleGene Knockdown TechniquesH-2 AntigensHumansInfluenza A virusMembrane GlycoproteinsMiceMice, Inbred C57BLMice, TransgenicPeptide FragmentsAntigens, ViralAntiviral AgentsendoplasminH-2 AntigensH-2Kb protein, mouseMembrane GlycoproteinsPeptide FragmentsRNA, Small Interfering

Identifiers

PMID19752220
PMCPMC2749969
OpenAlexW2107870292

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.